KINS Inc. Joins 'Innovation Infusion Japan (i2.JP)'
NQ Score
100/100
AI Summary (NQ-processed)
KINS Inc. has joined the open innovation network 'Innovation Infusion Japan (i2.JP),' led by AstraZeneca, as a partner company. By collaborating with various stakeholders, KINS aims to accelerate the social implementation of solutions utilizing its microbiome expertise to address healthcare challenges.
AI analysis data is not yet available.